The forecast for malignant neoplasms of the cervix uteri mortality in Canada shows a slight decline over the next five years. From a standardized rate of 1.9 in 2024, the rate decreases to 1.8 by 2026 and stabilizes through 2028. Comparing the data, the annual decrement from 2025 onward is consistently slight, indicating a small percentage decrease. The compound annual growth rate (CAGR) over the period from 2024 to 2028 reflects a stable yet slightly declining trend.

Future trends to watch for:

Developments in preventive healthcare, such as vaccination and screening programs, might further impact mortality rates positively.
Public health initiatives and access to healthcare services, particularly for underserved communities, could affect these trends.
Research advancements in treatment options and early detection methods could contribute to decreased mortality rates.